Relapse prevention with second generation tyrosine kinase inhibitors for Ph+ve acute leukemia after allogenic stem cell transplantation.

Faiz Anwer,Zabih Warraich,Atif Sohail,Theresa Thai,Azka Latif,Vikas Kapoor,Keri Renee Maher,Faiza Hassan Warraich,Sami Warraich,Zeeshan Baig,Adeela Mushtaq,Pavan Tenneti,Ali McBride

Relapse prevention with second generation tyrosine kinase inhibitors for Ph+ve acute leukemia after allogenic stem cell transplantation.

2018

Faiz Anwer
Zabih Warraich
Atif Sohail
Theresa Thai
Azka Latif
Vikas Kapoor
Keri Renee Maher
Faiza Hassan Warraich
Sami Warraich
Zeeshan Baig
Adeela Mushtaq
Pavan Tenneti
Ali McBride

7050Background: Relapse after allogeneic hematopoietic stem cell transplantation (AlloHSCT) for Ph+ve acute lymphoblastic leukemia (Ph+ ALL) remains the major cause of treatment failure. Use of tyr...

Keywords:

Relapse prevention
Stem cell
Tyrosine kinase
Transplantation
Acute leukemia
Cancer research
Pathology
Medicine
Lymphoblastic Leukemia
Hematopoietic stem cell transplantation
treatment failure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations